An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD Patients

NCT02799784 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: UMEC/VI
DRUG: TIO/OLO
DRUG: Albuterol/salbutamol

Sponsor

GlaxoSmithKline